Induced pluripotent stem cells (iPS) derived disease models: In vivo to in vitro gaps
暂无分享,去创建一个
[1] S. Kiselev,et al. Mitochondrial distribution violation and nuclear indentations in neurons differentiated from iPSCs of Huntington’s disease patients , 2018, Journal of stem cells & regenerative medicine.
[2] Nazish Sayed,et al. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond , 2018, Development.
[3] Malin Parmar,et al. Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era. , 2017, Cell stem cell.
[4] H. Ng,et al. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[5] G. Duda,et al. Functional Comparison of Chronological and In Vitro Aging: Differential Role of the Cytoskeleton and Mitochondria in Mesenchymal Stromal Cells , 2012, PloS one.
[6] M. Hendrix,et al. A Model of Cancer Stem Cells Derived from Mouse Induced Pluripotent Stem Cells , 2012, PloS one.
[7] Giovanni Staurenghi,et al. Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. , 2017, The New England journal of medicine.